New
HealthMore in Health →
Early glucagon changes in type 2 diabetes are being linked to fatty liver disease
A Medical Xpress report highlights research suggesting that early increases in glucagon in type 2 diabetes are associated with fatty liver disease, expanding the discussion beyond insulin alone.
Key Takeaways
- Medical Xpress reports research linking early glucagon increases in type 2 diabetes to fatty liver disease.
- The supplied extract says type 2 diabetes research has traditionally focused primarily on insulin.
DE
DT Editorial AI··via medicalxpress.com